News

Oil- and nut-supplemented Mediterranean diet improves elderly cognition


 

References

A Mediterranean diet supplemented by nuts or olive oil was associated with improved cognitive function in people aged 55-80 years, according to Cinta Valls-Pedret of the Institut d’Investigacions Biomèdiques August Pi Sunyer, Hospital Clínic, Barcelona, Spain, and associates.

Study participants on the Mediterranean diet plus olive oil scored significantly higher on the Rey Auditory Verbal Learning Test and the Color Trail Test part 2, compared with the control group on Mediterranean diet alone. Participants on the nuts and olive oil Mediterranean diet either kept their memory composite, frontal cognition composite, and global cognition composite scores close to the baseline or increased them slightly, while those on the control diet saw significantly decreased scores in all areas.

“The beneficial effect of Mediterranean diets on cognition probably stems from the abundance of antioxidants and anti-inflammatory agents that they provide. The supplemental foods, extra virgin olive oil and nuts, are particularly rich in phenolic compounds that might counteract oxidative processes in the brain, leading to neurodegeneration,” the authors noted.

Find the full study in JAMA Internal Medicine (2015 May 11 [doi:10.1001/jamainternmed.2015.1668]).

Recommended Reading

VIDEO: NAFLD increasingly causing U.S. hepatocellular carcinomas
MDedge Internal Medicine
PAS: Device decreases hospitalization costs for bronchiolitis
MDedge Internal Medicine
VIDEO: Consider adult ADHD in dementia differential diagnosis
MDedge Internal Medicine
Older psoriasis patients experience more adverse events
MDedge Internal Medicine
Applications expand for vorapaxar in cardiovascular prevention
MDedge Internal Medicine
AAS: Experts say suicide research needs a reboot
MDedge Internal Medicine
ILC: Statins linked to better outcomes in hepatitis C cirrhosis
MDedge Internal Medicine
AAN: OnabotulinumtoxinA injections reduce migraine hospitalizations
MDedge Internal Medicine
AAGP: Treating Parkinson’s psychosis takes balance on risk/benefit tightrope
MDedge Internal Medicine
AAN: Largest neuroleptic malignant syndrome study finds predictors of poor outcome
MDedge Internal Medicine